ORMP - oramed.com Qarzning balans kapitallashuviga nisbati

Oramed Pharmaceuticals Inc. (ORMP) grafik logotipi

Oramed Pharmaceuticals oral insulinni ishlab chiqayotgani va kuchli ilmiy salohiyati bilan bioximiklarni jalb qilmoqda. Tarixiy qarzning kitob kapitalizatsiyasiga nisbati moliyaviy barqarorlikni namoyish etadi, bunda 0.00 ko'rsatkichi ushbu darajani belgilaydi. Moslashuvchan R&D tuzilmasi va aksiyalar opsion dasturlari iste'dodli mutaxassislarni rag'batlantiradi, ishlab chiqarishni tashqi pudratchilarga topshiruvchi virtual biznes modeli esa kompaniyaning operatsion xarajatlarini optimallashtiradi.

ORMP (Oramed Pharmaceuticals Inc.) Qarzning balans qiymatiga nisbati tarixi 04.07.2022dan 27.10.2026gacha

oramed.com (ORMP) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi Oramed Pharmaceuticals Inc.|ORMP - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati ORMP|ORMP - Qarz va naqd pullar hisobga olingan qiymat
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar Oramed Pharmaceuticals|ORMP - Kompaniyaning sof aktivlari|Bozor kapitallashuvining balans qiymatiga nisbati oramed.com|ORMP - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati Oramed Pharmaceuticals|ORMP - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Oramed Pharmaceuticals Inc.|ORMP - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans qiymatiga nisbati ORMP
Kompaniyaning barcha koʻrsatkichlari tahlili:ORMP Oramed Pharma
Oramed Pharmaceuticals Inc. asosiy tovari

Oramed Pharmaceuticals (ORMP) kompaniyasida og'iz orqali qabul qilinadigan proteinlarning yuqori aniqlikdagi logistikasi taqsimot infratuzilmasiga sezilarli kapital xarajatlarni talab qiladi. Ushbu xarajatlar majburiyatlar tuzilmasida aks etgan bo'lib, u emitentning umumiy balans kapitaliga nisbatan baholanadi. Ushbu ko'rsatkich haqiqiy qarz yukini o'lchaydi va biznes rivojlanishining qarz mablag'lariga qanchalik bog'liqligini belgilaydi. Ushbu metrikaning oshishi moliyaviy qizib ketish va defolt xavfi haqida signal beradi. Joriy qarz va kapital nisbatini tahlil qilish orqali investor kompaniyaning kengayish barqarorligini baholaydi.

Oramed Pharmaceuticals raqobatchilari

Balans kapitallashuviga qarzlar HLN (Haleon plc)|kenvue.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Verona Pharma (VRNA)|MENS: Qarzning sof aktivlarga nisbati|LGND (Ligand Pharma) - Qarzning balans kapitallashuviga nisbati|Amneal Corp (AMRX) - Qarzning balans qiymatiga nisbati|PRGO (Perrigo Company plc) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar alvotech.com (ALVO)|Liquidia (LQDA) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati GLPG (Galapagos N.V.)|ANIP: Qarzning balans kapitallashuviga nisbati|MNKD - Balans qiymatiga qarzlar|Qarzning balans qiymatiga nisbati Amphastar Pharmaceuticals AMPH|PCRX - Qarzning balans kapitaliga nisbati|Balans kapitallashuviga qarzlar ARS Pharmaceuticals, Inc. SPRY|Theravance Biopharma Inc (TBPH) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar AQST (Aquestive Pharma)|Balans qiymatiga qarzlar SCPH|Tectonic Therapeutic, Inc. (TECX) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati TNXP (tonixpharma.com)|SXTC: Qarzning balans kapitallashuviga nisbati|Eupraxia Pharmaceuticals, Inc. - Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati BioHarvest (BHST)|EXOZ - Qarzning sof aktivlarga nisbati|ENTX: Balans kapitallashuviga qarzlar|HYFT (ipatherapeutics.com) - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati ABVC|Qarzning balans qiymatiga nisbati Cumberland Pharmaceuticals Inc|Quantum BioPharma Limited - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar FibroGen Corporation (FGEN)|TELO - Balans kapitallashuviga qarzlar|RANI - Qarzning balans qiymatiga nisbati|Qarzning balans qiymatiga nisbati Synergy CHC Corporation (SNYR)|RLYB: Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati lexariabioscience.com (LEXX)|Pulmatrix Corporation (PULM) - Qarzlarning balans kapitallashuviga nisbati|PTHL - Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati Aptorum|Balans kapitallashuviga qarzlar LYRA|Balans kapitallashuviga qarzlar IBO (Impact BioMedical, Inc.)|Qarzning balans kapitallashuviga nisbati TNF Pharmaceuticals, Inc.|cbdMD Inc. - Qarzning sof aktivlarga nisbati|PRFX: Qarzning balans kapitallashuviga nisbati|CYTO - Qarzning balans qiymatiga nisbati|LIPO: Balans kapitallashuviga qarzlar|OptiNose Inc (OPTN) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar PIRS|Qarzning balans qiymatiga nisbati Procaps Group Corp|Petros Pharmaceuticals - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar qlsyy.net QLI|Qarzning balans qiymatiga nisbati SLRN (ACELYRIN)|TFFP - Balans kapitallashuviga qarzlar